Get the Stockscreener App
11.47
6.50%
0.70
Certara Inc stock is traded at $11.47, with a volume of 1.18M.
It is up +6.50% in the last 24 hours and up +8.00% over the past month.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.
See More
Previous Close:
$10.77
Open:
$10.93
24h Volume:
1.18M
Relative Volume:
0.73
Market Cap:
$1.84B
Revenue:
$405.76M
Net Income/Loss:
$7.98M
P/E Ratio:
229.40
EPS:
0.05
Net Cash Flow:
$77.47M
1W Performance:
+4.08%
1M Performance:
+8.00%
6M Performance:
-12.91%
1Y Performance:
-11.77%
1-Day Range:
$10.84
$11.55
1-Week Range:
$10.59
$11.55
52-Week Range:
$8.635
$15.69
Certara Inc Stock (CERT) Company Profile
Name
Certara Inc
Sector
Industry
Phone
(415) 237-8272
Address
4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR
Compare CERT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CERT
Certara Inc
|
11.47 | 1.80B | 405.76M | 7.98M | 77.47M | 0.05 |
|
VEEV
Veeva Systems Inc
|
290.86 | 46.10B | 2.86B | 780.66M | 1.19B | 4.72 |
|
TEM
Tempus Ai Inc
|
80.52 | 13.63B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
67.74 | 12.35B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
89.82 | 7.74B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.24 | 6.32B | 906.14M | -52.62M | 89.62M | -0.3621 |
Certara Inc Stock (CERT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-03-25 | Resumed | Morgan Stanley | Equal-Weight |
| May-08-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Feb-27-25 | Initiated | TD Cowen | Buy |
| Sep-27-24 | Upgrade | UBS | Neutral → Buy |
| Apr-10-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-04-24 | Initiated | JMP Securities | Mkt Perform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-07-23 | Initiated | UBS | Neutral |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Aug-22-23 | Downgrade | Jefferies | Buy → Hold |
| Aug-10-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Apr-03-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-08-22 | Initiated | Berenberg | Buy |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-01-22 | Initiated | Piper Sandler | Overweight |
| Jan-11-22 | Upgrade | Jefferies | Hold → Buy |
| Aug-05-21 | Resumed | Credit Suisse | Neutral |
| Jul-23-21 | Initiated | Robert W. Baird | Outperform |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jan-06-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jan-05-21 | Initiated | BofA Securities | Buy |
| Jan-05-21 | Initiated | Credit Suisse | Neutral |
| Jan-05-21 | Initiated | Jefferies | Hold |
| Jan-05-21 | Initiated | William Blair | Outperform |
View All
Certara Inc Stock (CERT) Latest News
Biosimulation Market to Attain USD 18.97 Billion by 2034, Rising at 16.9% CAGR - GlobeNewswire Inc.
RSI Crosses Above 30 for Certara Inc. — Reversal in Sight2025 Sector Review & Daily Profit Maximizing Tips - metal.it
Sector Leaders Rotate Capital Into Certara Inc.2025 Pullback Review & Free Daily Entry Point Trade Alerts - metal.it
What makes Certara Inc. stock price move sharplyBull Run & AI Forecasted Entry and Exit Points - 선데이타임즈
Published on: 2025-08-15 22:51:02 - Newser
What MACD signals say about Certara Inc.2025 Technical Overview & Stock Timing and Entry Methods - Newser
Evaluating Certara Inc. with trendline analysisQuarterly Earnings Summary & Reliable Price Breakout Signals - Newser
Is this a good reentry point in Certara Inc.Weekly Trend Summary & Low Risk High Win Rate Stock Picks - Newser
Long term hold vs stop loss in Certara Inc.Market Risk Summary & Safe Entry Trade Signal Reports - Newser
How Certara Inc. stock performs during market volatilityTrade Risk Assessment & Weekly High Momentum Picks - Newser
Is it time to cut losses on Certara Inc.Earnings Risk Report & Risk Controlled Swing Trade Alerts - Newser
Using Ichimoku Cloud for Certara Inc. technicalsOptions Play & High Win Rate Trade Alerts - Newser
Certara (CERT) Q2 Revenue Jumps 12% - AOL.com
Live market analysis of Certara Inc.Trade Signal Summary & Real-Time Volume Triggers - Newser
Technical signs of recovery in Certara Inc.2025 Analyst Calls & Daily Profit Maximizing Trade Tips - Newser
Key External Factors That Drive Certara Inc. Stock Price MovementsWeekly Investment Summary & Risk Adjusted Buy/Sell Alerts - Newser
How Resilient Is Certara Inc. Stock During Economic DownturnsTrade Volume Summary & Long-Term Growth Plans - Newser
Shareholders Will Be Pleased With The Quality of Certara's (NASDAQ:CERT) Earnings - simplywall.st
Price action breakdown for Certara Inc.Market Growth Review & Low Risk Entry Point Tips - Newser
Can trapped investors hope for a rebound in Certara Inc.Weekly Market Report & AI Optimized Trade Strategies - Newser
Certara’s SWOT analysis: biosimulation firm’s stock faces growth hurdles By Investing.com - Investing.com Nigeria
Certara’s SWOT analysis: biosimulation firm’s stock faces growth hurdles - Investing.com
Certara (CERT) Is Up 9.0% After Simcyp Simulator Wins EMA Qualification and Q2 Sales Rise—Has the Bull Case Changed? - simplywall.st
Sectors Driving Future Growth for Certara Inc. StockDay Trading Setup Forecast with Trend Model - Newser
Certara Second Quarter 2025 Earnings: EPS Beats Expectations - Yahoo Finance
Certara, Inc. Reports Strong Q2 2025 Earnings Growth - TipRanks
Certara, Inc. Reports Strong Q2 2025 Growth - TipRanks
Here's Why It's Unlikely That Certara, Inc.'s (NASDAQ:CERT) CEO Will See A Pay Rise This Year - 富途牛牛
UBS Group Cuts Certara (NASDAQ:CERT) Price Target to $15.00 - Defense World
Can Traders Expect Breakout From Certara Inc. This WeekLow Capital High Return Stock Plans Reviewed - beatles.ru
Intrinsic Value of Certara Inc. Stock: Is It Undervalued or OvervaluedFree High Growth Low Risk Stock Selection - Newser
Certara signals full year 8–10% revenue growth outlook as AI and QSP momentum builds - MSN
Certara, Inc. (NASDAQ:CERT) Q2 2025 Earnings Call Transcript - Insider Monkey
Certara's Financials Obscure Share Price Momentum: What's Next? - AInvest
Certara, Inc.'s (NASDAQ:CERT) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock? - Yahoo Finance
Certara (CERT) Receives a Buy from UBS - The Globe and Mail
Certara, Inc. (CERT) Q2 Earnings Miss Estimates - MSN
Certara 2025 Q2 Earnings Narrows Losses, Reports 84.3% Reduction in Net Loss - AInvest
Navigator Holdings Ltd. shares fall 1.00% intraday after Certara, Inc. reports Q2 2025 earnings. - AInvest
Certara, Inc. (CERT): A Bull Case Theory - Insider Monkey
UBS Maintains Certara (CERT) Rating, Lowers Price Target to $15. - GuruFocus
Leerink Partners lowers Certara stock price target to $11.50 on valuation concerns By Investing.com - Investing.com South Africa
Leerink Partners lowers Certara stock price target to $11.50 on valuation concerns - Investing.com Nigeria
Certara Surges 15.58% Amid Volatile Intraday Action—What’s Fueling the Rally? - AInvest
UBS Adjusts Price Target on Certara to $15 From $17.50, Maintains Buy Rating - MarketScreener
Certara Grows In Q2 But Falls Short Of Analyst Estimates - Finimize
Earnings call transcript: Certara misses Q2 2025 EPS forecast, stock dips By Investing.com - Investing.com South Africa
Earnings call transcript: Certara misses Q2 2025 EPS forecast, stock dips - Investing.com
Certara’s Mixed Signals: Hold Rating Amidst Growth Potential and Strategic Uncertainty - TipRanks
Certara's Q2 Results and Strategic Positioning Support Buy Rating with $16 Price Target - AInvest
Decoding Certara Inc (CERT): A Strategic SWOT Insight - GuruFocus
Certara Inc Stock (CERT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Certara Inc Stock (CERT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Corcoran Daniel | SVP and General Counsel |
May 30 '25 |
Option Exercise |
0.00 |
22,828 |
0 |
20,530 |
| WALSH MATTHEW M | Director |
May 21 '25 |
Option Exercise |
0.00 |
11,928 |
0 |
197,559 |
| Reynders John V W | Director |
May 21 '25 |
Option Exercise |
0.00 |
10,709 |
0 |
10,709 |
| Killefer Nancy | Director |
May 21 '25 |
Option Exercise |
0.00 |
11,928 |
0 |
36,089 |
| Crane Rosemary A | Director |
May 21 '25 |
Option Exercise |
0.00 |
11,928 |
0 |
29,915 |
| Collins Cynthia | Director |
May 21 '25 |
Option Exercise |
0.00 |
11,928 |
0 |
36,089 |
| CASHMAN JAMES E III | Chairman |
May 21 '25 |
Option Exercise |
0.00 |
11,928 |
0 |
468,440 |
| BROSHY ERAN | Chairman |
May 21 '25 |
Option Exercise |
0.00 |
11,928 |
0 |
34,951 |
| Aspbury Robert | PRESIDENT, PREDICTIVE TECH |
Apr 01 '25 |
Option Exercise |
0.00 |
26,626 |
0 |
311,936 |
| Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL OFF |
Apr 01 '25 |
Option Exercise |
0.00 |
26,626 |
0 |
127,669 |
1.72%
0.81%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):